These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33674140)

  • 1. Clinicopathologic factors associated with malignant transformation of oral leukoplakias: a retrospective cohort study.
    Jäwert F; Pettersson H; Jagefeldt E; Holmberg E; Kjeller G; Öhman J
    Int J Oral Maxillofac Surg; 2021 Nov; 50(11):1422-1428. PubMed ID: 33674140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.
    Lee JJ; Hung HC; Cheng SJ; Chen YJ; Chiang CP; Liu BY; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):472-80. PubMed ID: 16545712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients.
    Liu W; Wang YF; Zhou HW; Shi P; Zhou ZT; Tang GY
    BMC Cancer; 2010 Dec; 10():685. PubMed ID: 21159209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk assessment of malignant transformation of oral leukoplakia in patients with previous oral squamous cell carcinoma.
    Yang SW; Lee YC; Lee YS; Chang LC; Lai YR
    Int J Oral Maxillofac Surg; 2022 Nov; 51(11):1394-1400. PubMed ID: 35249786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation.
    Wils LJ; Poell JB; Brink A; Evren I; Brouns ER; de Visscher JGAM; Bloemena E; Brakenhoff RH
    Clin Cancer Res; 2023 Feb; 29(3):602-613. PubMed ID: 36449687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant transformation of oral verrucous leukoplakia: a clinicopathologic study of 53 cases.
    Liu W; Shen XM; Liu Y; Li J; Zhou ZT; Wang LZ
    J Oral Pathol Med; 2011 Apr; 40(4):312-6. PubMed ID: 21342275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment outcome of oral premalignant lesions.
    Holmstrup P; Vedtofte P; Reibel J; Stoltze K
    Oral Oncol; 2006 May; 42(5):461-74. PubMed ID: 16316774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMI-1 expression increases in oral leukoplakias and correlates with cell proliferation.
    Klein IP; Meurer L; Danilevicz CK; Squarize CH; Martins MD; Carrard VC
    J Appl Oral Sci; 2020; 28():e20190532. PubMed ID: 32348447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric analysis of nuclear DNA content in oral leukoplakia: relation to clinicopathologic findings.
    Saito T; Yamashita T; Notani K; Fukuda H; Mizuno S; Shindoh M; Amemiya A
    Int J Oral Maxillofac Surg; 1995 Feb; 24(1 Pt 1):44-7. PubMed ID: 7782640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant Transformation Rate of Non-reactive Oral Hyperkeratoses Suggests an Early Dysplastic Phenotype.
    Stojanov IJ; Woo SB
    Head Neck Pathol; 2022 Jun; 16(2):366-374. PubMed ID: 34255278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomogram for risk prediction of malignant transformation in oral leukoplakia patients using combined biomarkers.
    Zhang X; Kim KY; Zheng Z; Bazarsad S; Kim J
    Oral Oncol; 2017 Sep; 72():132-139. PubMed ID: 28797449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between clinical and histopathological characteristics in oral leukoplakia.
    Evren I; Brouns ER; Poell JB; Wils LJ; Brakenhoff RH; Bloemena E; de Visscher JGAM
    Oral Dis; 2023 Mar; 29(2):696-706. PubMed ID: 34601770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semiquantifiable angiogenesis parameters in association with the malignant transformation of oral leukoplakia.
    Thiem DGE; Schneider S; Venkatraman NT; Kumar VV; Brieger J; Frerich B; Kämmerer PW
    J Oral Pathol Med; 2017 Oct; 46(9):710-716. PubMed ID: 28036153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia.
    Xia RH; Song XM; Wang XJ; Li J; Mao L
    PLoS One; 2013; 8(6):e66794. PubMed ID: 23826135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High malignant transformation rate of widespread multiple oral leukoplakias.
    Saito T; Sugiura C; Hirai A; Notani K; Totsuka Y; Shindoh M; Kohgo T; Fukuda H
    Oral Dis; 1999 Jan; 5(1):15-9. PubMed ID: 10218036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant transformation of oral leukoplakia: Systematic review and meta-analysis of the last 5 years.
    Aguirre-Urizar JM; Lafuente-Ibáñez de Mendoza I; Warnakulasuriya S
    Oral Dis; 2021 Nov; 27(8):1881-1895. PubMed ID: 33606345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Identification of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression].
    Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E
    Ned Tijdschr Tandheelkd; 2021 Feb; 128(2):103-111. PubMed ID: 33605260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of nomogram for prediction of malignant transformation in oral leukoplakia: A large-scale cohort study.
    Wang T; Wang L; Yang H; Lu H; Zhang J; Li N; Guo CB
    J Oral Pathol Med; 2019 Jul; 48(6):491-498. PubMed ID: 30980769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annual malignant transformation rate of oral leukoplakia remains consistent: A long-term follow-up study.
    Evren I; Brouns ER; Wils LJ; Poell JB; Peeters CFW; Brakenhoff RH; Bloemena E; de Visscher JGAM
    Oral Oncol; 2020 Nov; 110():105014. PubMed ID: 33038723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands.
    Schepman KP; van der Meij EH; Smeele LE; van der Waal I
    Oral Oncol; 1998 Jul; 34(4):270-5. PubMed ID: 9813722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.